Bogdan-tiberius Preca
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer.
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer.
Journal: Journal of mammary gland biology and neoplasia
Published: October 06, 2022
N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer.
Journal: Cell reports. Medicine
Published: August 08, 2022
A high-throughput drug screen reveals means to differentiate triple-negative breast cancer.
Journal: Oncogene
Published: January 04, 2022
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells.
Journal: Nature structural & molecular biology
Published: November 22, 2018
ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma.
Journal: Molecular oncology
Published: August 09, 2018
KDM4 Inhibition Targets Breast Cancer Stem-like Cells.
Journal: Cancer research
Published: June 22, 2017
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
Journal: Oncotarget
Published: August 15, 2016
ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat.
Journal: EMBO molecular medicine
Published: April 16, 2015
A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
Journal: International journal of cancer
Published: November 01, 2014
The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors.
Journal: Oncotarget
Published: October 22, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026